Folgen
Konstantin Yenkoyan
Konstantin Yenkoyan
Yerevan State Medical University after M.Heratsi
Bestätigte E-Mail-Adresse bei meduni.am - Startseite
Titel
Zitiert von
Zitiert von
Jahr
Advances in understanding the pathophysiology of autism spectrum disorders
K Yenkoyan, A Grigoryan, K Fereshetyan, D Yepremyan
Behavioural brain research 331, 92-101, 2017
1372017
A certain role of SOD/CAT imbalance in pathogenesis of autism spectrum disorders
K Yenkoyan, H Harutyunyan, A Harutyunyan
Free Radical Biology and Medicine 123, 85-95, 2018
662018
Proline-rich polypeptides in Alzheimer's disease and neurodegenerative disorders—Therapeutic potential or a mirage?
A Gladkevich, F Bosker, J Korf, K Yenkoyan, H Vahradyan, M Aghajanov
Progress in Neuro-Psychopharmacology and Biological Psychiatry 31 (7), 1347-1355, 2007
422007
Neuroprotective action of proline-rich polypeptide-1 in β-amyloid induced neurodegeneration in rats
K Yenkoyan, K Safaryan, V Chavushyan, I Meliksetyan, G Navasardyan, ...
Brain research bulletin 86 (3-4), 262-271, 2011
402011
Prognostic indicators and outcomes of hospitalised COVID-19 patients with neurological disease: An individual patient data meta-analysis
B Singh, S Lant, S Cividini, JWS Cattrall, LC Goodwin, L Benjamin, ...
PLoS One 17 (6), e0263595, 2022
372022
Assessment of behavioral, morphological and electrophysiological changes in prenatal and postnatal valproate induced rat models of autism spectrum disorder
K Fereshetyan, V Chavushyan, M Danielyan, K Yenkoyan
Scientific reports 11 (1), 23471, 2021
372021
Intranasal losartan decreases perivascular beta amyloid, inflammation, and the decline of neurogenesis in hypertensive rats
HJ Drews, K Yenkoyan, A Lourhmati, M Buadze, D Kabisch, ...
Neurotherapeutics 16, 725-740, 2019
372019
Modeling neurodegenerative disorders in zebrafish
AA Bashirzade, KN Zabegalov, AD Volgin, AS Belova, KA Demin, ...
Neuroscience & Biobehavioral Reviews 138, 104679, 2022
362022
Effects of beta-amyloid on behavioral and amino acids spectrum in rats’ brain and their modulation by embryonic proteins
K Yenkoyan, K Safaryan, G Navasardyan, L Mkrtchyan, M Aghajanov
Neurochemistry international 54 (5-6), 292-298, 2009
242009
The role of monoamines in the development of Alzheimer's disease and neuroprotective effect of a proline rich polypeptide
K Yenkoyan, K Fereshetyan, S Matinyan, V Chavushyan, M Aghajanov
Progress in Neuro-Psychopharmacology and Biological Psychiatry 86, 76-82, 2018
192018
The synergy of β amyloid 1-42 and oxidative stress in the development of Alzheimer’s disease-like neurodegeneration of hippocampal cells
G Karapetyan, K Fereshetyan, H Harutyunyan, K Yenkoyan
Scientific Reports 12 (1), 17883, 2022
172022
Kinetics of anti-nucleocapsid IgG response in COVID-19 immunocompetent convalescent patients
M Movsisyan, A Chopikyan, I Kasparova, G Hakobjanyan, F Carrat, ...
Scientific Reports 12 (1), 12403, 2022
162022
Neuroprotective, neurogenic, and amyloid beta reducing effect of a novel alpha 2-Adrenoblocker, mesedin, on astroglia and neuronal progenitors upon hypoxia and glutamate exposure
MM Melkonyan, L Hunanyan, A Lourhmati, N Layer, S Beer-Hammer, ...
International Journal of Molecular Sciences 19 (1), 9, 2017
152017
Brain-derived neurotrophic factor (BDNF) in perinatal depression: side show or pivotal factor?
S Singh, K Fereshetyan, S Shorter, R Paliokha, E Dremencov, ...
Drug Discovery Today 28 (2), 103467, 2023
142023
Novel probable glance at inflammatory scenario development in autistic pathology
AA Harutyunyan, HA Harutyunyan, KB Yenkoyan
Frontiers in Psychiatry 12, 788779, 2021
142021
Alzheimer's disease-like pathology-triggered oxidative stress, alterations in monoamines levels, and structural damage of locus coeruleus neurons are partially recovered by a …
M Aghajanov, V Chavushyan, S Matinyan, M Danielyan, K Yenkoyan
Neurochemistry International 131, 104531, 2019
142019
α2-Adrenergic receptor in liver fibrosis: implications for the adrenoblocker mesedin
UA Schwinghammer, MM Melkonyan, L Hunanyan, R Tremmel, ...
Cells 9 (2), 456, 2020
132020
Current state of modeling human psychiatric disorders using zebrafish
FV Costa, TO Kolesnikova, DS Galstyan, NP Ilyin, MS de Abreu, ...
International Journal of Molecular Sciences 24 (4), 3187, 2023
92023
Disruption of cholinergic circuits as an area for targeted drug treatment of Alzheimer’s disease: In vivo assessment of short-term plasticity in rat brain
V Chavushyan, A Soghomonyan, G Karapetyan, K Simonyan, ...
Pharmaceuticals 13 (10), 297, 2020
92020
The proline-rich hypothalamic peptide is a modulator of functions of neurotrophins and neuronal activity in amyloid-induced neurodegeneration
MI Aghajanov, KB Yenkoyan, VA Chavushyan, JS Sarkissian
Neurochemical Journal 8, 47-57, 2014
82014
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20